Protalix BioTherapeutics, Inc. (PLX)
NYSEAMERICAN: PLX · Real-Time Price · USD
1.660
-0.030 (-1.78%)
Nov 21, 2024, 4:00 PM EST - Market closed
Protalix BioTherapeutics Stock Forecast
Stock Price Forecast
There is currently no analyst price target forecast available for PLX.
Analyst Consensus: n/a
Analyst Ratings
There are currently no analyst ratings available for PLX.
Recommendation Trends
| Rating | Jun '23 | Jul '23 | Aug '23 | Sep '23 | Oct '23 | Nov '23 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 1 | 1 | 0 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +502.41% | Nov 14, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $7 → $10 | Strong Buy | Maintains | $7 → $10 | +502.41% | Oct 31, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $11 → $7 | Strong Buy | Maintains | $11 → $7 | +321.69% | May 3, 2021 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $3 → $11 | Strong Buy | Maintains | $3 → $11 | +562.65% | Jun 8, 2020 |
| Rodman & Renshaw | Rodman & Renshaw | Strong Buy Reiterates $40 → $50 | Strong Buy | Reiterates | $40 → $50 | +2,912.05% | Apr 17, 2017 |
Financial Forecast
Revenue This Year
54.22M
from 65.49M
Decreased by -17.21%
Revenue Next Year
102.45M
from 54.22M
Increased by 88.94%
EPS This Year
0.02
from 0.09
Decreased by -76.69%
EPS Next Year
0.63
from 0.02
Increased by 3,000.00%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 56.4M | 106.5M | 175.6M |
| Avg | 54.2M | 102.5M | 168.9M |
| Low | 52.6M | 99.4M | 163.9M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -13.9% | 96.4% | 71.4% |
| Avg | -17.2% | 88.9% | 64.9% |
| Low | -19.7% | 83.3% | 60.0% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 0.02 | 0.65 | 1.19 |
| Avg | 0.02 | 0.63 | 1.14 |
| Low | 0.02 | 0.61 | 1.11 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -75.8% | 3,122.8% | 89.5% |
| Avg | -76.7% | 3,000.0% | 82.3% |
| Low | -77.4% | 2,907.9% | 76.8% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.